U.S. Wearable Injectors Market Size & Outlook, 2023-2030
U.S. wearable injectors market, 2018-2030 (US$M)
Related Markets
U.S. wearable injectors market highlights
- The U.S. wearable injectors market generated a revenue of USD 2,482.7 million in 2023 and is expected to reach USD 6,749.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 15.4% from 2024 to 2030.
- In terms of segment, on-body was the largest revenue generating type in 2023.
- Off-body is the most lucrative type segment registering the fastest growth during the forecast period.
Wearable injectors market data book summary
| Market revenue in 2023 | USD 2,482.7 million |
| Market revenue in 2030 | USD 6,749.4 million |
| Growth rate | 15.4% (CAGR from 2023 to 2030) |
| Largest segment | On-body |
| Fastest growing segment | Off-body |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | On-body, Off-body |
| Key market players worldwide | BD, Johnson & Johnson, Roche Holding AG, United Therapeutics Corp, Amgen Inc, Insulet Corp, West Pharmaceutical Services Inc, CeQur Simplicity, Unilife Corporation, Enable Injections |
Other key industry trends
- In terms of revenue, U.S. accounted for 28.2% of the global wearable injectors market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. wearable injectors market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 6,749.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Wearable Injectors Market Scope
Wearable Injectors Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. wearable injectors market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to wearable injectors market will help companies and investors design strategic landscapes.
On-body was the largest segment with a revenue share of 55.52% in 2023. Horizon Databook has segmented the U.S. wearable injectors market based on on-body, off-body covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in healthcare spending, rise in government initiatives, and high disposable income are some of the factors contributing to market growth. In addition, high per capita income, favorable reimbursement scenario, and rise in prevalence of chronic diseases requiring long-term care are likely to boost the wearable injectors market in the U.S.
Moreover, rapid technological advancements, presence of key manufacturers in the region, increase in R&D investments, and rise in government funding & initiatives are expected to boost the market growth in the coming years.
Furthermore, Insulet Corporation, Amgen, Inc., Unilife Corporation, BD, and Johnson & Johnson Services, Inc. are some of the key players operating in the U.S. Companies are adopting various strategies, such as mergers & acquisitions, partnerships & collaborations, and new product launches & approvals to gain a competitive edge in the market.
Reasons to subscribe to U.S. wearable injectors market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. wearable injectors market databook
-
Our clientele includes a mix of wearable injectors market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. wearable injectors market , including forecasts for subscribers. This country databook contains high-level insights into U.S. wearable injectors market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. wearable injectors market size, by type, 2018-2030 (US$M)
U.S. Wearable Injectors Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
